![1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione structure](/static/products/304/304871-61-2.png)
1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione
TL;DR: 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione (CAS 304871-61-2) is a chemical compound with molecular formula C18H32N6O2 and molecular weight 364.26 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione
Also Known As: 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione, 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione
| Molecular Formula | C18H32N6O2 |
|---|---|
| Molecular Weight | 364.26 g/mol |
| LogP | 1.1 |
| Topological Polar Surface Area | 53.6 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Exact Mass | 364.25867 |
| Heavy Atoms | 26 |
| Complexity | 502.0 |
Chemical Identifiers
| CAS Number | 304871-61-2 |
|---|---|
| SMILES | CN1C2C(N(C1=O)C)N(C(=O)N2CN3CCCCC3)CN4CCCCC4 |
| InChIKey | VXQIGHVZYQZUHN-UHFFFAOYSA-N |
Product Overview
1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione (CAS 304871-61-2), with molecular formula C18H32N6O2 and molecular weight 364.26 g/mol. IUPAC: 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione.
Chemical Property Profile of 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione
Property Insights of 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione
The XLogP value of 1.1 suggests moderate lipophilicity, balancing water solubility and membrane permeability for 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione. With a topological polar surface area (TPSA) of 53.6 Ų, 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione has 0 hydrogen bond donor(s) and 4 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione?
The CAS number of 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione is 304871-61-2.
What is the molecular formula of 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione?
The molecular formula of 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione is C18H32N6O2.
What is the molecular weight of 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione?
The molecular weight of 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione is 364.26 g/mol.
Where can I buy 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione?
You can request a quote for 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione?
Yes, KEHONG BIO provides custom synthesis services for 1,3-dimethyl-4,6-bis(piperidin-1-ylmethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.